These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1797050)

  • 1. Protection against the lethal effect and arthritogenic capacity of Yersinia enterocolitica serovar O:3 for mice.
    de los Toyos JR; Díaz R; Hardisson C
    FEMS Microbiol Immunol; 1991 Oct; 3(5):289-97. PubMed ID: 1797050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of plasmid-encoded antigens of Yersinia enterocolitica in humoral immunity against secondary Y. enterocolitica infection in mice.
    Vogel U; Autenrieth IB; Berner R; Heesemann J
    Microb Pathog; 1993 Jul; 15(1):23-36. PubMed ID: 8412625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virulence, persistence, and immunogenicity of Yersinia enterocolitica O:8 aroA mutants.
    Bowe F; O'Gaora P; Maskell D; Cafferkey M; Dougan G
    Infect Immun; 1989 Oct; 57(10):3234-6. PubMed ID: 2777382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yersinia enterocolitica serotype O:3 is arthritogenic for mice.
    de los Toyos JR; Vázquez J; Sampedro A; Hardisson C
    Microb Pathog; 1990 May; 8(5):363-70. PubMed ID: 2215184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive immunization with monoclonal antibodies specific for lipopolysaccharide (LPS) O-side chain protects mice against intravenous Yersinia enterocolitica serotype O:3 infection.
    Skurnik M; Mikkola P; Toivanen P; Tertti R
    APMIS; 1996; 104(7-8):598-602. PubMed ID: 8920815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral infection by Y. enterocolitica 0:8. Studies of immunization in a murine model].
    Frades MC; Díaz R
    Enferm Infecc Microbiol Clin; 1991 Dec; 9(10):608-12. PubMed ID: 1822150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant bivalent fusion protein rVE confers active and passive protection against Yersinia enterocolitica infection in mice.
    Singh AK; Kingston JJ; Murali HS; Batra HV
    Vaccine; 2014 Mar; 32(11):1233-9. PubMed ID: 24486353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-resistance to fecal excretion of Yersinia enterocolitica in mice by oral vaccination of killed cells.
    Kaneko K; Hashimoto N
    Infect Immun; 1983 Jun; 40(3):1223-5. PubMed ID: 6852921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective immunity induced by a Yersinia enterocolitica serovar 0:8 cellular extract.
    Di Genaro MS; Escudero ME; Maccioni M; Stefanini de Guzmán AM
    Biocell; 1996 Dec; 20(3):235-41. PubMed ID: 9031590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immune response in Yersinia enterocolitica O:5 induced arthritis in hamsters.
    Di Genaro MS; Escudero ME; Velázquez LC; Muñoz E; Aguilera C; Juárez A; Scardapane L; Stefanini de Guzmán AM
    Microbiol Immunol; 1997; 41(8):615-20. PubMed ID: 9310941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of mice against parenteral and oral infection with Yersinia enterocolitica.
    Nakajima R; Kaneko K; Hashimoto N
    Nihon Juigaku Zasshi; 1984 Oct; 46(5):721-7. PubMed ID: 6513245
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of protective immunity induced by Yersinia enterocolitica type-III secretion system mutants.
    Mamroud E; Flashner Y; Tidhar A; Ber R; Gur D; Aftalion M; Lazar S; Velan B; Shafferman A; Cohen S
    Adv Exp Med Biol; 2003; 529():425-30. PubMed ID: 12756803
    [No Abstract]   [Full Text] [Related]  

  • 13. DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria.
    Noll A; Bücheler N; Bohn E; Schirmbeck R; Reimann J; Autenrieth IB
    Eur J Immunol; 1999 Mar; 29(3):986-96. PubMed ID: 10092103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the Yersinia enterocolitica 0:8 V antigen for cross protectivity.
    Schmidt A; Schaffelhofer S; Müller K; Röllinghoff M; Beuscher HU
    Microb Pathog; 1999 Apr; 26(4):221-33. PubMed ID: 10089162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An experimental mouse model of Yersinia-induced reactive arthritis.
    Yong Z; Hill JL; Hirofuji T; Mander M; Yu DT
    Microb Pathog; 1988 Apr; 4(4):305-10. PubMed ID: 3200165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of
    Kasperkiewicz K; Świerzko AS; Przybyła M; Szemraj J; Barski J; Skurnik M; Kałużyński A; Cedzyński M
    J Immunol Res; 2020; 2020():7439506. PubMed ID: 33274243
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunomodulation by Yersinia enterocolitica: comparison of live and heat-killed bacteria.
    Ruiz-Bravo A; Bujalance C; Romero F; Moreno E; Jimenez-Valera M
    FEMS Immunol Med Microbiol; 2003 Dec; 39(3):229-33. PubMed ID: 14642307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an LPS-based ELISA for diagnosis of Yersinia enterocolitica O:3 infections in Danish patients: a follow-up study.
    Dalby T; Rasmussen E; Schiellerup P; Krogfelt KA
    BMC Microbiol; 2017 May; 17(1):125. PubMed ID: 28545413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental Yersinia-associated arthritis in the spontaneously hypertensive rat.
    Toivanen P; Merilahti-Palo R; Gripenberg C; Söderström KO; Jaakkola UM
    Br J Rheumatol; 1988; 27 Suppl 2():52-4. PubMed ID: 3401653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The serodiagnosis of human infections with Yersinia enterocolitica and Yersinia pseudotuberculosis.
    Chart H; Cheasty T
    FEMS Immunol Med Microbiol; 2006 Aug; 47(3):391-7. PubMed ID: 16872375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.